[ad_1] Novartis’ Farydak was approved by the FDA to treat multiple myeloma in 2015. Now scientists in Australia believe the drug can be combined with an early-phase clinical agent to tackle neuroblastoma, a …
Read More »Could a combo of cancer drugs for adults also treat neuroblastoma in children?
